Back to top

messenger-rna: Archive

Zacks Equity Research

Pfizer (PFE) Touts RSV Jab Benefit in Immunocompromised Adults

Results from a late-stage study show that Pfizer's (PFE) RSV vaccine generated strong neutralizing responses in immunocompromised adults after receiving a single dose.

GSKNegative Net Change PFENegative Net Change MRNANegative Net Change

Zacks Equity Research

Moderna (MRNA) Q2 Earnings Beat, Stock Down on Guidance Slash

Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.

MRKNegative Net Change MRNANegative Net Change HALONegative Net Change TRDANegative Net Change

Zacks Equity Research

GSK Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance

GSK's revenues benefit from strong growth across the Specialty Medicines and General Medicines segments. It raises guidance for earnings and sales for the full year.

SNYNegative Net Change GSKNegative Net Change JNJNegative Net Change VIRNegative Net Change